Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma

References

• Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P, et al. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol – a groupe d'Etude des lymphomes de l'Adulte study. J Clin Oncol 2000; 18: 3025–3030
   PubMed Web of Science ®Google Scholar
• Bouabdallah R, Coso D, Costello R, Bardou V J, Blaise D, Xerri L, et al. Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center. Bone Marrow Transplant 2000; 25: 35–40
   PubMed Web of Science ®Google Scholar
• Gianni A M, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997; 336: 1290–1297
   PubMed Web of Science ®Google Scholar
• Veelken H, Vik Dannheim S, Schulte Moenting J, Martens U M, Finke J, Schmitt-Graeff A. Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy. Ann Oncol 2007; 18: 931–939
   PubMed Web of Science ®Google Scholar
• Dalton W S, Friend S H. Cancer biomarkers – an invitation to the table. Science 2006; 312: 1165–1168
   PubMed Web of Science ®Google Scholar
• Winter J N, Weller E A, Horning S J, Krajewska M, Variakojis D, Habermann T M, et al. Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study. Blood 2006; 107: 4207–4213
   PubMed Web of Science ®Google Scholar
• Sanchez-Beato M, Sanchez-Aguilera A, Piris M A. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101: 1220–1235
   PubMed Web of Science ®Google Scholar
• de Jong D, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Lee A, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications – a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol 2007; 25: 805–812
   PubMed Web of Science ®Google Scholar
• Arranz R, Conde E, Grande C, Mateos M V, Gandarillas M, Albo C, et al. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group. Eur J Haematol 2008; 80: 227–235
   PubMed Web of Science ®Google Scholar
• Jaffe E S, World Health Organization. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumors. IARC Press, Oxford University Press (distributor, Lyon, Oxford 2001; 3: 351
   Google Scholar
• Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L, et al. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol 2002; 161: 1825–1837
   PubMed Web of Science ®Google Scholar
• Sanchez-Aguilera A, Montalban C, de la Cueva P, Sanchez-Verde L, Morente M M, Garcia-Cosio M, et al. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 2006; 108: 662–668
   PubMed Web of Science ®Google Scholar
• Vaquerizas J M, Dopazo J, Diaz-Uriarte R. DNMAD: web-based diagnosis and normalization for microarray data. Bioinformatics 2004; 20: 3656–3658
   PubMed Web of Science ®Google Scholar
• Montanan D, Tarraga J, Huerta-Cepas J, Burguet J, Vaquerizas J M, Conde L, et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Res 2006; 34(Web Server issue)W486–W491
   Google Scholar
• Rodriguez A, Villuendas R, Yanez L, Gomez M E, Diaz R, Pollan M, et al. Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation. Leukemia 2007; 21: 1984–1991
   PubMed Web of Science ®Google Scholar
• Dave S S, Wright G, Tan B, Rosenwald A, Gascoyne R D, Chan W C, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159–2169
   PubMed Web of Science ®Google Scholar
• Tusher V G, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–5121
   PubMed Web of Science ®Google Scholar
• Gutierrez N C, Lopez-Perez R, Hernandez J M, Isidro I, Gonzalez B, Delgado M, et al. Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia. Leukemia 2005; 19: 402–409
   PubMed Web of Science ®Google Scholar
• Herrero J, Al-Shahrour F, Diaz-Uriarte R, Mateos A, Vaquerizas J M, Santoyo J, et al. GEPAS: a web-based resource for microarray gene expression data analysis. Nucleic Acids Res 2003; 31: 3461–3467
   PubMed Web of Science ®Google Scholar
• Saez A I, Saez A J, Artiga M J, Perez-Rosado A, Camacho F I, Diez A, et al. Building an outcome predictor model for diffuse large B-cell lymphoma. Am J Pathol 2004; 164: 613–622
   PubMed Web of Science ®Google Scholar
• Carreras J, Lopez-Guillermo A, Fox B C, Colomo L, Martinez A, Roncador G, et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006; 108: 2957–2964
   PubMed Web of Science ®Google Scholar
• D.C.T. R. R: A language and environment for statistical computing. V. R Foundation for Statistical Computing, Editor, Austria 2007
   Google Scholar
• Hans C P, Weisenburger D D, Greiner T C, Gascoyne R D, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275–282
   PubMed Web of Science ®Google Scholar
• Colomo L, Lopez-Guillermo A, Perales M, Rives S, Martinez A, Bosch F, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003; 101: 78–84
   PubMed Web of Science ®Google Scholar
• Monti S, Savage K J, Kutok J L, Feuerhake F, Kurtin P, Mihm M, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105: 1851–1861
   PubMed Web of Science ®Google Scholar
• Hasselblom S, Sigurdadottir M, Hansson U, Nilsson-Ehle H, Ridell B, Andersson P O. The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma. Br J Haematol 2007; 137: 364–373
   PubMed Web of Science ®Google Scholar
• Alvaro T, Lejeune M, Salvado M T, Bosch R, Garcia J F, Jaen J, et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005; 11: 1467–1473
   PubMed Web of Science ®Google Scholar
• Lee A M, Clear A J, Calaminici M, Davies A J, Jordan S, MacDougall F, et al. Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 2006; 24: 5052–5059
   PubMed Web of Science ®Google Scholar
• Tzankov A, Meier C, Hirschmann P, Went P, Pileri S A, Dirnhofer S. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 2008; 93: 193–200
   PubMed Web of Science ®Google Scholar
• Lee N R, Song E K, Jang K Y, Choi H N, Moon W S, Kwon K, et al. Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis. Leuk Lymphoma 2008; 49: 247–256
   PubMed Web of Science ®Google Scholar
• Curiel T J, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942–949
   PubMed Web of Science ®Google Scholar
• Yang Z Z, Novak A J, Stenson M J, Witzig T E, Ansell S M. Intratumoral CD4+ CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 2006; 107: 3639–3646
   PubMed Web of Science ®Google Scholar
• van Imhoff G W, Boerma E J, van der Holt B, Schuuring E, Verdonck L F, Kluin-Nelemans H C, et al. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 4135–4142
   PubMed Web of Science ®Google Scholar